Basic Information
ExThera Medical focuses on therapeutic applications to treat drug-resistant and susceptible bloodstream infections in high-risk patient populations, as well as a field-deployable version for biodefense and military use. The company’s first product, the Seraph® 100 Microbind® Affinity Blood Filter, is CE-marked for reducing pathogens during bloodstream infections as an adjunct to antibiotics and is commercially available in Europe.
ExThera Medical Corporation
California,United States of America
unclear
January 01, 2007
info@extheramedical.com

